20 January 2016Immunocore Starts Clinical Trial with IMCgp100 in Combination with MedImmune Immunotherapies Durvalumab and Tremelimumab
20 January 2016Immunocore Starts Clinical Trial with IMCgp100 in Combination with MedImmune Immunotherapies Durvalumab and Tremelimumab
06 January 2016Immunocore and GlaxoSmithKline Select First ImmTAC Clinical Candidate in Discovery Collaboration
03 December 2015Immunocore wins Biotech of the Year at the SCRIP Awards 2015
09 September 2015Immunocore’s IMCgp100 Accepted for Adaptive Pathway Pilot Programme
07 September 2015Immunocore Ranked No 1 South East Company in the Annual Sunday Times Hiscox Tech Track 100